» Articles » PMID: 25751747

The Methyltransferase Ezh2 Controls Cell Adhesion and Migration Through Direct Methylation of the Extranuclear Regulatory Protein Talin

Abstract

A cytosolic role for the histone methyltransferase Ezh2 in regulating lymphocyte activation has been suggested, but the molecular mechanisms underpinning this extranuclear function have remained unclear. Here we found that Ezh2 regulated the integrin signaling and adhesion dynamics of neutrophils and dendritic cells (DCs). Ezh2 deficiency impaired the integrin-dependent transendothelial migration of innate leukocytes and restricted disease progression in an animal model of multiple sclerosis. Direct methylation of talin, a key regulatory molecule in cell migration, by Ezh2 disrupted the binding of talin to F-actin and thereby promoted the turnover of adhesion structures. This regulatory effect was abolished by targeted disruption of the interactions of Ezh2 with the cytoskeletal-reorganization effector Vav1. Our studies reveal an unforeseen extranuclear function for Ezh2 in regulating adhesion dynamics, with implications for leukocyte migration, immune responses and potentially pathogenic processes.

Citing Articles

Polycomb repressive complex 2 (PRC2) pathway's role in cancer cell plasticity and drug resistance.

Goleij P, Heidari M, Tabari M, Hadipour M, Rezaee A, Javan A Funct Integr Genomics. 2025; 25(1):53.

PMID: 40048009 DOI: 10.1007/s10142-025-01563-8.


The epigenetic hallmarks of immune cells in cancer.

Ji Y, Xiao C, Fan T, Deng Z, Wang D, Cai W Mol Cancer. 2025; 24(1):66.

PMID: 40038722 PMC: 11881328. DOI: 10.1186/s12943-025-02255-4.


Enhancer zeste homolog 2 (EZH2) targeting by small interfering RNA (siRNA); recent advances and prospect.

Hsu C, Mohammed A, Hjazi A, Uthirapathy S, Renuka J, Singh A Naunyn Schmiedebergs Arch Pharmacol. 2025; .

PMID: 39960560 DOI: 10.1007/s00210-025-03883-9.


ROS regulates circadian rhythms by modulating Ezh2 interactions with clock proteins.

Zhang H, Li K, Wang Y, Wei C, Gao Y, Ren-Zhou Redox Biol. 2025; 81:103526.

PMID: 39952198 PMC: 11875201. DOI: 10.1016/j.redox.2025.103526.


Exploring oncogenic roles and clinical significance of EZH2: focus on non-canonical activities.

Wozniak M, Czyz M Ther Adv Med Oncol. 2025; 17():17588359241306026.

PMID: 39776536 PMC: 11705335. DOI: 10.1177/17588359241306026.


References
1.
Goksoy E, Ma Y, Wang X, Kong X, Perera D, Plow E . Structural basis for the autoinhibition of talin in regulating integrin activation. Mol Cell. 2008; 31(1):124-33. PMC: 2522368. DOI: 10.1016/j.molcel.2008.06.011. View

2.
Kruidenier L, Chung C, Cheng Z, Liddle J, Che K, Joberty G . A selective jumonji H3K27 demethylase inhibitor modulates the proinflammatory macrophage response. Nature. 2012; 488(7411):404-8. PMC: 4691848. DOI: 10.1038/nature11262. View

3.
Ren X, Kiosses W, Sieg D, Otey C, Schlaepfer D, Schwartz M . Focal adhesion kinase suppresses Rho activity to promote focal adhesion turnover. J Cell Sci. 2000; 113 ( Pt 20):3673-8. DOI: 10.1242/jcs.113.20.3673. View

4.
Coxon A, Rieu P, Barkalow F, Askari S, Sharpe A, von Andrian U . A novel role for the beta 2 integrin CD11b/CD18 in neutrophil apoptosis: a homeostatic mechanism in inflammation. Immunity. 1996; 5(6):653-66. DOI: 10.1016/s1074-7613(00)80278-2. View

5.
Bedford M, Clarke S . Protein arginine methylation in mammals: who, what, and why. Mol Cell. 2009; 33(1):1-13. PMC: 3372459. DOI: 10.1016/j.molcel.2008.12.013. View